Skip to content
‹ Back to IndustriesSciences

What Impact Does the Coronavirus have on Global Business?

The potentially lasting effects of the Coronavirus, like those of the early-aughts SARS outbreak and the early-2010s’ avian-flu scare, are being felt not only in China, but across the globe. Originating in Wuhan, China, a city with a population of more than 10 million people, Coronavirus has kicked off a fast-spreading epidemic in the heart…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Ben Thomas · · ClosingCoronavirusDiseaseFactories
Share
What Impact Does the Coronavirus have on Global Business?

Key takeaways

01

The potentially lasting effects of the Coronavirus, like those of the early-aughts SARS outbreak and the early-2010s’ avian-flu scare, are being felt not only in China, but across the globe.

02

Originating in Wuhan, China, a city with a population of more than 10 million people, Coronavirus has kicked off a fast-spreading epidemic in the heart…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The potentially lasting effects of the Coronavirus, like those of the early-aughts SARS outbreak and the early-2010s’ avian-flu scare, are being felt not only in China, but across the globe.

Originating in Wuhan, China, a city with a population of more than 10 million people, Coronavirus has kicked off a fast-spreading epidemic in the heart of Chinese manufacturing.

That location has resulted in ripple effects throughout the global economy as businesses that rely on Chinese manufacturing scramble for answers and investors and forecasters have a finger on the world economy’s proverbial panic button.

What outcomes and impacts are most likely in the wake of the disease?

Manufacturing Receives a Gut Punch

Though recent trends regarding the U.S. Institute for Supply Management seemed to suggest a renewed manufacturing boom – or at least a return to growth after a lengthy slowdown, the Coronavirus outbreak has thrown a China-sized wrench squarely in the middle of that progress.

Major players across a variety of industries are feeling the effects – from the actual act of shipping goods around the world to impacts on the oil and gas, construction and steel, and automotive industries, among others, manufacturing’s contraction is almost certain to put a hefty squeeze on the world’s production and transportation capabilities.

Tech, Even Among Giants, Hit Hard

In particular, the technology sector could be left reeling from the lengthening shuttering of Chinese production.

Apple has already closed all of the company’s offices and stores in China through Sunday, and factories for both the American tech giant and other major players could follow suit depending on the continued severity of the outbreak.

Analysts at Goldman Sachs predicted a 1.6-percentage-point drop in China’s first-quarter GDP growth, and a recommendation from the U.S. Centers for Disease Control and Prevention has spurred employers as large as Microsoft, Facebook and Amazon to implement various restrictions on travel in recent days.

Like companies across all the industries impacted by the outbreak, tech companies will be left scrambling for replacement manufacturing solutions if they mean to keep up with demand and avoid skidding off the road entirely.

The Global Economy Is in Flux

China’s central bank has already pledged to pump an enormous sum of money into the country’s economy in a last-ditch attempt to head off the worst of the disease’s financial impact, and markets around the globe are reacting negatively to the uncertainty surround the outbreak.

In the U.S., stocks are rebounding as a result of this attempted stimulus, as investors saw the DOW Jones Industrial Average balloon more than 400 points to fight back against recent dips related to the disease.

If previous American market reactions to similar outbreaks, which have been largely much ado about nothing, are to be trusted, the temporary panic could subside and give way to clearer heads, more central-bank stimulation and a steadier-than-expected market.

However, should the disease continue to spread and gain a more impactful stranglehold on the Chinese economy, there’s still a very real possibility for more disruption.

–

For the latest news, videos, and podcasts in B2B, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

Ben Thomas
Ben ThomasHead of Pro AV, MarketScale

Ben Thomas serves as Head of Pro AV at MarketScale, where he leads content and media strategy for the pro AV sector. With over 15 years of award-winning experience across large-scale events, network television, OTT platforms, and podcasting, he has guided major B2B brands including Intel, Sennheiser, Samsung, and Philips to billions of content interactions. He holds a B.A. in Mass Communications and is recognized for his expertise in podcast hosting, public speaking, marketing, and content strategy.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

IndexBox sees replacements driving a third of quantum cascade laser shipments by 2030

IndexBox sees replacements driving a third of quantum cascade laser shipments by 2030

The quantum cascade laser market is projected to grow 8% to 12% a year through 2035, driven by mid-infrared spectroscopy in process control, environmental monitoring and pharmaceutical quality checks. In these uses, the lasers offer high spectral brightness and run at room temperature in compact form factors. The installed base of analytical instruments is also growing.

  • 01Roughly one in three quantum cascade lasers shipped in 2030 is projected to replace equipment already in service, so maintenance calendars will set a growing share of demand.
  • 02For a plant or QA lab running QCL-based analyzers, the useful question is which laser maker sits inside each instrument and whether a second source exists.
  • 03Analyzers bought on a three-to-five-year cycle in 2026 come due between 2029 and 2031. Those years will show whether the forecast replacement wave turns up in real orders.

Oct 26, 2026

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu cites digitalization, personalization and large-volume delivery as trends reshaping drug delivery devices, arguing structured data can enable reuse and cut duplicated design-file work for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of IV and SC agents.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan prefilled syringe plant in Shenzhen won the Innovation (Novel Technology) category at ISPE's 2026 Facility of the Year Awards. In the transcript ISPE posted with its podcast, CaiXue Wei describes vertical design, AGV-assisted transfer, AI inspection and 5G-MEC as one integrated system built around a 330 million-syringe annual capacity; Hepalink's own release adds a 24-meter warehouse, sub-10 millisecond 5G and 24,000-unit-an-hour inspection.

  • 01Hepalink's 24-meter automated warehouse raised space utilization 52 percent over a traditional layout on a land-scarce Shenzhen site supporting 330 million syringes a year.
  • 02AGVs pass material through vaporized hydrogen peroxide chambers straight into Grade A isolators, and Hepalink credits the zero-touch flow for a 100 percent first media fill.

Oct 22, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

Ben Thomas
Ben Thomas

Head of Pro AV

MarketScale

Ben Thomas serves as Head of Pro AV at MarketScale, where he leads content and media strategy for the pro AV sector. With over 15 years of award-winning experience across large-scale events, network television, OTT platforms, and podcasting, he has guided major B2B brands including Intel, Sennheiser, Samsung, and Philips to billions of content interactions. He holds a B.A. in Mass Communications and is recognized for his expertise in podcast hosting, public speaking, marketing, and content strategy.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512